Japan Intellectual Property Rights: METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[B]PYRIDINE-3-CARBOXYLATE AND METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE-3-CARBOXYLATE AS CAV1.2 ACTIVATORS

Japan, April 14 -- NOVARTIS AG has got intellectual property rights for 'METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[B]PYRIDINE-3-CARBOXYLATE AND METHYL 2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE-3-CARBOXYLATE AS CAV1.2 ACTIVATORS.' Other related details are as follows:

Application Number: JP,2024-212164

Category (FI): A61K31/435,A61K31/4355,A61K9/20,A61K9/48,A61P25/00,A61P25/18,A61P25/24,A61P25/28,A61P25/30,A61P9/00,C07D221/04,C07D491/048

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 5, 2024

Publication Date: March 11, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.